Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma Patients
NCT05427513Phase 1Unknown
- Sponsor
- Shaukat Khanum Memorial Cancer Hospital & Research Centre
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial comparing placebo with tranexamic acid(TXA) (2 arms). Primary endpoints: Blood Loss at 72 hours and Number of Blood Transfused at 72 hours. Status: unknown.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT05427513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05427513.